| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/23/2002 | WO2002040644A1 Agent imparting resistance to external stimuli |
| 05/23/2002 | WO2002040640A2 Methods of using cd8+/tcr- facilitating cells (fc) for the engraftment of purified hematopoietic stem cells (hsc) |
| 05/23/2002 | WO2002040639A2 Methods for enhancing engraftment of purified hematopoietic stem cells in allogeneic recipients |
| 05/23/2002 | WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | WO2002040242A1 Electroprocessed collagen |
| 05/23/2002 | WO2002040051A1 Colostrum-based composition |
| 05/23/2002 | WO2002040050A1 Non-lethal methods for conditioning a recipient for bone marrow transplantation |
| 05/23/2002 | WO2002040049A2 Blockade of t cell migration into epithelial gvhd target tissues |
| 05/23/2002 | WO2002040042A2 Method for optimally delivering virus to a solid tumor mass |
| 05/23/2002 | WO2002040013A1 Composition for stimulating the immune defence and iron metabolism, containing propionyl l-carnitine and lactoferrin |
| 05/23/2002 | WO2002039948A2 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 05/23/2002 | WO2002039885A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | WO2002039834A1 Nutritional composition for an immune condition |
| 05/23/2002 | WO2002005866A3 Deployment system for myocardial cellular material |
| 05/23/2002 | WO2001088103A9 Compositions and methods for tissue dedifferentiation and regeneration |
| 05/23/2002 | WO2001087346A3 Dendritic cells loaded with toxic substances |
| 05/23/2002 | WO2001083715A3 Derivation of midbrain dopaminergic neurons from embryonic stem cells |
| 05/23/2002 | WO2001081577A3 Dna encoding the prost 03 polypeptide |
| 05/23/2002 | WO2001081549A3 Hepatocyte lineage cells derived from pluripotent stem cells |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001078753A3 Therapeutic uses for mesenchymal stromal cells |
| 05/23/2002 | WO2001078752A3 Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs |
| 05/23/2002 | WO2001053506A3 Virus strains for the oncolytic treatment of cancer |
| 05/23/2002 | WO2001049316A3 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization |
| 05/23/2002 | WO2001049304A3 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 05/23/2002 | WO2001040271A9 Cancer associated antigens and uses therefor |
| 05/23/2002 | US20020062488 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 05/23/2002 | US20020062023 Palau'amine; treatment of tumors, fungal infections and immunosuppressive affections. |
| 05/23/2002 | US20020061846 Administering to a mammal Group B- beta hemolytic streptococci(GBS) toxin receptors or immunogenic fragments to induce an immune response to the GBS receptors for prventing pathoangiogenic conditions |
| 05/23/2002 | US20020061592 Liquid or frozen mixture for use in maintaince of viral particles; for use in gene therapy |
| 05/23/2002 | US20020061587 Treating cardiovascular disorders and tissue; obtain tissue, incubate with cytokines, graft somatic stem cells, monitor tissue adjustment in activity |
| 05/23/2002 | US20020061553 Partners of the PTB1 domain of FE65, preparation and uses |
| 05/23/2002 | US20020061535 Monitoring sample for preferential particles; obtain sample, incubate on test column, wash column, incubate with probes, wash column, detect signals |
| 05/23/2002 | US20020061517 Adenovirus carrying gag gene HIV vaccine |
| 05/23/2002 | US20020061514 Assay for identifying modulators of chondrogenesis |
| 05/23/2002 | US20020061337 Administering water and/or fat-soluble cytosolic extract of pollen with Royal Jelly and Vitamin E to treat hormonal variations in fertile, peri- and post- menopausal women |
| 05/23/2002 | US20020061310 Compositions and methods for dendritic cell-based immunotherapy |
| 05/23/2002 | US20020061298 Method for optimally delivering virus to a solid tumor mass |
| 05/23/2002 | US20020061295 Myocardial grafts and cellular compositions useful for same |
| 05/23/2002 | US20020061294 Mononuclear phagocytes in therapeutic drug delivery |
| 05/23/2002 | US20020061293 Transduced human hematopoietic stem cells |
| 05/23/2002 | US20020061292 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/23/2002 | CA2429460A1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | CA2428805A1 Method for optimally delivering virus to a solid tumor mass |
| 05/23/2002 | CA2428748A1 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 05/23/2002 | CA2428721A1 Blockade of t cell migration into epithelial gvhd target tissues |
| 05/23/2002 | CA2427902A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/22/2002 | EP1206568A2 Target for antiparasitic agents and inhibitors thereof |
| 05/22/2002 | EP1206563A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 05/22/2002 | EP1206535A1 Tumor-associated antigen (r11) |
| 05/22/2002 | EP1206525A2 Method for growing stem cells |
| 05/22/2002 | EP1206523A1 Bifidobacteria preventing diarrhea caused by pathogenic bacteria |
| 05/22/2002 | EP1206491A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 05/22/2002 | EP1206284A1 Method for delivery of therapeutic agents using a solution of dextrin |
| 05/22/2002 | EP1206267A1 Medicaments that contain xenogenic oligo- or/and polyribonucleotides |
| 05/22/2002 | EP1206242A1 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1206225A2 In vitro repair of bone and/or cartilage defects |
| 05/22/2002 | EP0746329B1 Anti-inflammatory factor containing compositions, method of production, and use |
| 05/22/2002 | CN1350548A Long lasting insulinotropic peptides |
| 05/22/2002 | CN1350547A Alleviation of the alelrgenic potential of airborne and contact allergens by thioredoxin |
| 05/22/2002 | CN1350462A Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses |
| 05/22/2002 | CN1350461A Lactobacillus strain preventing diarrhoea pathogenic bacteria |
| 05/22/2002 | CN1350460A Lactic acid bacteria strains capable of preventing diarrhoea |
| 05/22/2002 | CN1349826A Lingguo extract capsule and its prepn. method |
| 05/22/2002 | CN1349812A Composite medicine for treating myocardosis and its prepn |
| 05/22/2002 | CN1349801A Yin nourishing and kidney reinforcing medicine |
| 05/22/2002 | CN1085099C Medicine for treating thyroid enlargement thyrodism |
| 05/22/2002 | CN1085098C Medicine for treating mastoplasia |
| 05/22/2002 | CN1085097C Medicine for treating prostatic hyperplasia |
| 05/22/2002 | CN1085096C Ointment for curing burn, empyrosis and wound infection and preparation method thereof |
| 05/22/2002 | CN1085095C Preparation method of medicine Huanshen xingnao for curing encephalomyelopathy |
| 05/22/2002 | CN1085093C Oral liquor for treating male infertility |
| 05/22/2002 | CN1085085C Chinese drug for curing rheumatism and its producing technology |
| 05/22/2002 | CN1085081C Compound fish oil |
| 05/21/2002 | US6392013 Redirection of cellular immunity by protein tyrosine kinase chimeras |
| 05/21/2002 | US6391864 Glucosamine mixtures |
| 05/21/2002 | US6391832 Medical emulsion for lubrication and delivery of drugs |
| 05/21/2002 | US6391632 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 05/21/2002 | US6391615 Isolate of Antrodia camphorata process for producing a culture of the same and product obtained thereby |
| 05/21/2002 | US6391579 Nucleotide sequences coding transport protein for use in the treatment of thyroid defects |
| 05/21/2002 | US6391323 Composition comprising, as active ingredients, chlorophyll, cod liver oil, camphor, and antiseptic agent selected from niaouli oil, thyme oil, and mixtures thereof, provided in pharmaceutically acceptable vehicle for topical application |
| 05/21/2002 | US6391306 Treatment of infectious diseases with hsp90-peptide complexes |
| 05/21/2002 | US6391298 Method of using PON-1 to decrease atheroma formation |
| 05/21/2002 | US6391297 Differentiation of adipose stromal cells into osteoblasts and uses thereof |
| 05/16/2002 | WO2002039117A1 Methods for the treatment of cellular proliferative disorders |
| 05/16/2002 | WO2002039116A2 Retrovirus isolated from humans |
| 05/16/2002 | WO2002038741A1 Cell reprogramming |
| 05/16/2002 | WO2002038726A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/16/2002 | WO2002038616A2 Resin based on polystyrene functionalised by methyl ester groups of l-tyrosine and their uses |
| 05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | WO2002038601A2 Foggy |
| 05/16/2002 | WO2002038596A1 Method of identifying antibacterial compounds |
| 05/16/2002 | WO2002038169A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 05/16/2002 | WO2002038168A2 Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases |
| 05/16/2002 | WO2002038165A1 Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome |
| 05/16/2002 | WO2002038164A1 Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
| 05/16/2002 | WO2002038163A1 Bone putty and method |
| 05/16/2002 | WO2002038123A1 A skin cream composition |
| 05/16/2002 | WO2002038104A2 Compositions and methods for reducing the amount of salmonella in livestock |